SE444809B - Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar - Google Patents

Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar

Info

Publication number
SE444809B
SE444809B SE7713233A SE7713233A SE444809B SE 444809 B SE444809 B SE 444809B SE 7713233 A SE7713233 A SE 7713233A SE 7713233 A SE7713233 A SE 7713233A SE 444809 B SE444809 B SE 444809B
Authority
SE
Sweden
Prior art keywords
halogensoric
oxiimino
cefem
societies
alfa
Prior art date
Application number
SE7713233A
Other languages
English (en)
Other versions
SE7713233L (sv
Inventor
M Ochiai
O Aki
A Morimoto
T Okada
K Kawakita
Y Matsushita
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7713233L publication Critical patent/SE7713233L/sv
Priority to JP1336578A priority Critical patent/JPS53121400A/ja
Publication of SE444809B publication Critical patent/SE444809B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7713233A 1975-06-09 1977-11-23 Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar SE444809B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1336578A JPS53121400A (en) 1977-02-07 1978-02-07 Method of supplying fuel with aeroplane and device for the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24611/75A GB1536281A (en) 1975-06-09 1975-06-09 Cephem compounds

Publications (2)

Publication Number Publication Date
SE7713233L SE7713233L (sv) 1977-11-23
SE444809B true SE444809B (sv) 1986-05-12

Family

ID=10214399

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7713233A SE444809B (sv) 1975-06-09 1977-11-23 Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar

Country Status (7)

Country Link
JP (5) JPS5822039B2 (sv)
AT (2) AT344894B (sv)
GB (1) GB1536281A (sv)
HK (1) HK2282A (sv)
HU (1) HU172304B (sv)
MY (1) MY8200219A (sv)
SE (1) SE444809B (sv)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
FR2346014A1 (fr) * 1976-01-23 1977-10-28 Roussel Uclaf Nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof
FI771866A (sv) * 1976-06-28 1977-12-29 Fujisawa Pharmaceutical Co
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
AU520269B2 (en) * 1977-03-14 1982-01-21 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
JPS5444695A (en) * 1977-09-13 1979-04-09 Fujisawa Pharmaceut Co Ltd 3,7-disubstituted-3-cephem-4-carboxylic acid and its salt and their preparation
US4370326A (en) * 1977-09-13 1983-01-25 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and composition
FR2410655A1 (fr) * 1977-12-05 1979-06-29 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2758001A1 (de) * 1977-12-24 1979-07-12 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
JPS54106495A (en) * 1978-02-09 1979-08-21 Dai Ichi Seiyaku Co Ltd Cephem derivative
JPS54128594A (en) * 1978-03-27 1979-10-05 Fujisawa Pharmaceut Co Ltd 3,7-disubstituted-3-cephem-4-carboxylic acid derivative
FR2432521A1 (fr) * 1978-03-31 1980-02-29 Roussel Uclaf Nouvelles oximes o-substituees derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2818263A1 (de) * 1978-04-26 1979-11-08 Bayer Ag Beta-lactamantibiotika
US4703046A (en) * 1978-09-08 1987-10-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
BE878637A (fr) * 1978-09-11 1980-03-06 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3-cephem-4-carboxylique 3,7-disubstitue et de leurs sels pharmaceutiquement acceptables, nouveaux produits ainsi obtenus et leur utilisation pour leurs activites antimicrobiennes
JPS5594354A (en) * 1979-01-12 1980-07-17 Fujisawa Pharmaceut Co Ltd Syn-isomer of 2-substituted imino-3-oxo-4-halobutyric acid, its salt, and their preparation
JPS5543089A (en) * 1978-09-12 1980-03-26 Fujisawa Pharmaceut Co Ltd Preparation of 3-cephem compound
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
JPS56125392A (en) * 1980-03-06 1981-10-01 Fujisawa Pharmaceut Co Ltd Cepham and cephem compound and preparation thereof
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
ATE30724T1 (de) 1982-06-28 1987-11-15 Bristol Myers Co Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS6150973A (ja) * 1983-11-16 1986-03-13 Fujisawa Pharmaceut Co Ltd 置換イミノ酢酸誘導体およびその塩類
IT1180207B (it) * 1984-07-30 1987-09-23 Istituto Biochimico Italiano Procedimento per la preparazione, con resa e purezza elevate, di antibiotici beta-lattamici
JPS60155167A (ja) * 1984-07-31 1985-08-15 Fujisawa Pharmaceut Co Ltd 置換イミノ酢酸誘導体およびその塩類
JPS61121746U (sv) * 1985-01-16 1986-07-31
EP0210815A3 (en) * 1985-07-25 1988-04-20 Beecham Group Plc 6-beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
WO1988005776A1 (en) * 1987-02-02 1988-08-11 Teijin Limited Cephalosporin compounds or their salts, process for their preparation, and parmaceutical compositions
EP0347459A4 (en) * 1987-02-03 1990-04-10 Teijin Ltd CEPHALOSPORIN COMPOUNDS OR SALTS THEREOF, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS.
JPH02281051A (ja) * 1989-04-21 1990-11-16 Toyo Tire & Rubber Co Ltd タイヤ用トレッドゴム組成物
JPH09110877A (ja) 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds

Also Published As

Publication number Publication date
JPS51149296A (en) 1976-12-22
ATA967775A (de) 1977-12-15
GB1536281A (en) 1978-12-20
JPS5756485A (en) 1982-04-05
JPS5822039B2 (ja) 1983-05-06
AT347587B (de) 1979-01-10
MY8200219A (en) 1982-12-31
HU172304B (hu) 1978-07-28
SE7713233L (sv) 1977-11-23
JPS5989686A (ja) 1984-05-23
JPS61143388A (ja) 1986-07-01
JPH0346474B2 (sv) 1991-07-16
ATA517177A (de) 1978-05-15
AT344894B (de) 1978-08-10
JPS58185553A (ja) 1983-10-29
HK2282A (en) 1982-01-22
JPS6155905B2 (sv) 1986-11-29
JPS5858353B2 (ja) 1983-12-24

Similar Documents

Publication Publication Date Title
SE444809B (sv) Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar
MX4717E (es) Procedimiento para la preparacion de derivados de pirrolidina
SE7602317L (sv) 1,4-dihydropyridinkarbonsyraalkylestrar till anvendning som lekemedel och sett att framstella desamma
NO142172C (no) Analogifremgangsmaate for fremstilling av som antikonvulsiva virksomme alfa-fenyl-benzyliden-aminosyrederivater
AR211339A1 (es) Procendimiento de preparacion de derivados de la tetrahidro tienopiridina
SE435289B (sv) O-substituerade 7 beta-amino-3-cefem-3-ol-4-karbonsyraderivat till anvendning som mellanprodukt for framstellning av o-substituerade 7 beta-acylamino-3-cefem-3-ol-4-karbonsyraderivat
MX5119E (es) Procedimiento mejorado para la preparacion de derivados de pirimidona
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
AR208361A1 (es) Procedimiento para la preparacion de derivados l-piroglutamil-l-histidil-3-alquil-prolinamida
SE440080B (sv) Forfarande for framstellning av klavulansyraderivat
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE409455B (sv) Analogiforfarande for framstellning av nitroimidazolyl-kinazolinderivat
SE7614091L (sv) Forfarande for framstellning av tiadiazolylderivat av 7-acylamido-3-cefem-4-karbonsyra
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7606815L (sv) Forfarande for framstellning av nya naftacenderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
AR217802A1 (es) Procedimiento para la preparacion de derivados de acido 3-oxo-d-homoandrost-4-eno-17a beta-carboxilico
AR215869A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-fenil-2-aminoetanol
SE7610968L (sv) Forfarande for framstellning av biologiskt aktiva di-karboxylsyraderivat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7713233-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7713233-0

Format of ref document f/p: F